# Local Steroid Treatment for Idiopathic Granulomatous Mastitis (LSTIGM)

> **NCT03766997** · PHASE4 · UNKNOWN · sponsor: **Peking Union Medical College Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Granulomatous Mastitis

## Interventions

- **DRUG:** Compound Betamethasone Injection
- **DRUG:** Hydrocortisone Butyrate 0.1% Cream

## Key facts

- **NCT ID:** NCT03766997
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-02-19
- **Primary completion:** 2021-01
- **Final completion:** 2022-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2020-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03766997

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03766997, "Local Steroid Treatment for Idiopathic Granulomatous Mastitis (LSTIGM)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03766997. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*